Please login to the form below

Not currently logged in
Email:
Password:

QuintilesIMS changes its name to IQVIA

Firm will focus on human data science solutions

IQVIAA year after its initial launch as QuintilesIMS, the pharma service provider has re-launched as IQVIA.

Its new name maintains parts of its original formation, with the ‘I’ representing IMS and the ‘Q’ taken from Quintiles.

However, the latter and newest part of the name - ‘via’  - is representative of “seeking to inspire and ignite real change via a new path forward”, explains Ari Bousbib, chief executive officer of IQVIA.

Bousbib added: “We launched as QuintilesIMS, then we built something transformational and that is how we became IQVIA.

“We aim to bring the potential of human data science to life to find better solutions for patients.”

The group has a slightly different offering from when it first became QuintilesIMS, which was due to a mega-merger of healthcare services provider Quintiles and information and technology group IMS, offering pharma clients an end-to-end clinical and commercial package.

Now, the newly-named group will provide solutions to healthcare companies through analytics, data science and human science, claiming expertise in research and development, real-world value and outcomes, commercialisation and technologies.

Article by
Gemma Jones

10th November 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...